How Common Is Bladder Cancer By Age?

Bladder cancer is one of the most frequently diagnosed cancers, and age plays a significant role in how often it occurs. While it can affect people at any stage of adulthood, the likelihood rises as you get older. 

Knowing the age patterns can help you understand risk factors, spot symptoms early, and make informed choices about your health.

How does bladder cancer occur?

Bladder cancer happens when abnormal cells begin to grow in the lining of the bladder. Over time, these cells can form tumours that may spread if left untreated. 

The most common type is called urothelial carcinoma, which starts in the cells lining the bladder. Other, less common forms include squamous cell carcinoma and adenocarcinoma.

Symptoms often include:

While these signs might also be linked to less serious issues like infections, they should never be ignored. Early detection can make a big difference to treatment outcomes.

The link between age and bladder cancer

Age is one of the strongest factors linked to bladder cancer. In the UK, it’s the tenth most common cancer overall, with around 10,000 new cases diagnosed each year. 

The risk increases steadily as people grow older. Most diagnoses are made in those over 60, and the majority are men. Bladder cancer is rare in younger adults, but the chances of developing it rise steeply once you reach later middle age.

Bladder cancer in people under 40

Bladder cancer is uncommon in people under 40, with this group making up fewer than 1 in 20 cases. When it does occur, it’s often picked up at an earlier stage, which usually makes it easier to treat. 

Younger patients may undergo different treatment considerations compared to older adults, since their overall health is often stronger.

The rarity of bladder cancer in this age group can sometimes cause delays in diagnosis. Doctors may first suspect other causes for urinary symptoms, meaning patients need to be persistent if problems continue. 

If you’re younger and notice blood in your urine or changes in bladder habits, it’s always worth seeking medical advice.

Bladder cancer in middle age

The likelihood of bladder cancer begins to rise after 40 and becomes more noticeable in the 50s and 60s. By this stage, long-term exposure to risk factors such as smoking or workplace chemicals starts to have a greater effect. Smoking is the biggest preventable cause, and its impact builds up over many years.

Middle-aged adults may also be more aware of changes in their health. This age group is often balancing careers, family responsibilities, and personal wellbeing, which can make it tempting to ignore small symptoms. 

Yet, recognising the warning signs and arranging timely medical checks could help detect bladder cancer before it progresses.

Bladder cancer in older adults

Most cases of bladder cancer occur in people aged 70 and over. In fact, nearly half of all new diagnoses in the UK are made in this age bracket. 

As the body ages, cells are more likely to undergo genetic changes that can lead to cancer. Combined with cumulative exposure to smoking or environmental risks, this explains why bladder cancer is most strongly linked with later life.

Older adults often have other medical conditions alongside bladder cancer, such as heart disease or diabetes. These factors sometimes influence which treatments are suitable. 

Even so, many older patients benefit from surgery, immunotherapy, or other therapies, especially when the cancer is caught early. Always consult with a healthcare professional before making decisions about treatment.

Why age matters in bladder cancer

Age not only influences how likely you are to develop bladder cancer but also shapes how it progresses and how treatment is planned. 

For younger patients, the cancer may be detected earlier and managed with less invasive approaches. For older patients, doctors may need to balance treatment with other health concerns.

Understanding the role of age helps highlight why bladder cancer isn’t approached in the same way for everyone. Personalised care that takes into account age, lifestyle history, and overall health is key to the best outcomes.

Other risk factors alongside age

Although age is a major factor, it doesn’t act alone. Bladder cancer risk is shaped by several influences, including:

  • Smoking: The leading risk factor, responsible for over a third of cases.
  • Workplace exposure: Jobs involving chemicals used in dyes, rubber, paint, or printing increase the risk.
  • Family history: Having relatives with bladder cancer slightly raises the chance of developing it yourself.
  • Chronic bladder irritation: Long-term catheter use or repeated infections may contribute to risk.
  • Gender: Men are around four times more likely to develop bladder cancer than women, though women often present with more advanced stages when diagnosed.

Even though you can’t change your age, you can take steps to reduce preventable risks, such as stopping smoking and staying hydrated.

Importance of early detection

Regardless of age, early detection of bladder cancer improves the chances of successful treatment. The most common early sign is blood in the urine, which may appear bright red or brownish. Sometimes it’s visible, and sometimes it’s only picked up on a urine test.

Other signs include needing to urinate more often, urgency, or pain when passing urine. These symptoms don’t always mean cancer, but they should always be checked. 

Simple diagnostic tools like cystoscopy and urine tests are commonly used to confirm whether bladder cancer is present.

Living with bladder cancer by age group

Living with bladder cancer is different depending on your stage of life.

  • Younger patients may face concerns about how treatment could affect fertility or long-term health. They might also find it emotionally challenging if friends and peers aren’t dealing with similar health issues.
  • Middle-aged patients often juggle work responsibilities and family commitments, which can add stress during treatment. Support from employers and loved ones becomes particularly important.
  • Older patients may need to think about how bladder cancer care interacts with other conditions. They might also rely more on family support during treatment and recovery.

Recognising these differences highlights why care needs to be tailored, not just to the cancer itself but also to the wider needs of the patient.

Support and prevention strategies

Preventing bladder cancer completely isn’t always possible, but reducing risks and staying alert to symptoms makes a real difference.

  • Quit smoking: Stopping at any age lowers your risk.
  • Stay hydrated: Drinking enough water helps flush toxins from your bladder.
  • Follow workplace safety rules: If you work with chemicals, protective equipment is essential.
  • Attend health checks: Especially important if you’re over 50 or have urinary symptoms.

Support can also come from counselling, patient networks, or educational resources. Having access to trusted information can ease anxiety and help you feel more prepared for each step of diagnosis or treatment.

Key takeaways

Bladder cancer is strongly linked with age. While rare in younger adults, the risk rises in middle age and is highest in people over 70. Age influences not just how common bladder cancer is, but also how it’s diagnosed and managed.

By staying aware of symptoms, addressing lifestyle risks, and seeking medical advice early, you can improve your chances of a positive outcome.

Related guide: Latest Treatments For Bladder Cancer.

Picture of Maneesh Ghei
Maneesh Ghei
Mr Maneesh Ghei MS MRCSEd MD (UCL) FRCS (Urol) is a highly experienced Consultant Urological Surgeon and founder of Urocare London, with over three decades of practice in both NHS and private settings across the capital. As Lead Cancer Clinician at Whittington Hospital, Archway, he chairs the multidisciplinary urology cancer meeting, overseeing patient care from diagnosis through to the latest minimally invasive treatments. A pioneer in complex endourology and stone disease management, Mr Ghei led the UK’s first randomised, double-blind trial of intradetrusor botulinum toxin for refractory overactive bladder. He holds an MBBS and MS in General Surgery from India, an MD from University College London, and undertook advanced fellowships in stone disease and laparoscopic surgery, culminating in his Fellowship of the Royal College of Surgeons (Urology). Committed to education and research, he supervises doctoral work in focal therapies and cryotherapy for prostate cancer and champions public awareness through annual Movember fundraising.
Scroll to Top